NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, announced today a new agreement with Harrison Clinical Research (HCR), an international full-service contract research organization. After notification that support for its previous CTMS solution would be discontinued, Harrison selected BioClinica OnPoint CTMS to replace that system. HCR decided that OnPoint is the best-in-class solution to provide services to its world-wide client base. Harrison currently supports approximately 80 clinical trials for its clients annually.
